hashimoto's disease glp 1 Exploring the Side Effects of GLP-1 Receptor Agonist: To Ensure Its Optimal Positioning Emerging Role of GLP-1 Receptor

PubMed Medical Disclaimer: This article is for informational and research purposes only

SpringerLink+2Anaesthetists Publications+2 That doesnt mean these medications are unsafe or that everyone on them will have complications

[1] It belongs to a novel class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists

In a phase 2 study, comparing the results of the empagliflozin arm to the control arm showed a significant improvement in the electrophysiological studies and a significant decrease in the pain score and the mean serum levels of neuron-specific enolase and malondialdehyde in patients with DPN